QUALITY_SYSTEM: ACTIVE BATCH_VERIFIED: YES

ITRAKAS 130 SB

CAPSULE REF: ITRAKAS_130_SB
MRP Discount Selling Price You Saved
₹ 229.69 0% ₹ 229.69 ₹ 0.00
Accepted files: PDF, JPG, PNG. Mandatory for regulatory records compliance.
PCODE 448
SALT COMPOSITION ITRACONAZOLE 130MG SB CAP
TYPE CAPSULE
PACKED IN ALU ALU
PACKING 10X10 CAP
THERAPEUTIC ANTI FUNGALS
MAIN CATEGORY Anti-Infective
PARENT MANUFACTURER HEALTHCARE

Product Overview

PHARMA INTEGRITY PROTOCOL

The Generic Advantage

Slide to visualize how artificial markups inflate branded medicine pricing, or compare the clinical facts below.

Interactive Cost Breakdown Simulator

Generic formulation Branded medicine
Direct Sourcing (Save up to 90%) Commercial Overhead & Markups
Active Ingredients & Mfg. ₹10
Estimated Patient Cost: ₹10
GENERIC_PROTOCOL_ACTIVE (100% Value)
RECOMMENDED PROTOCOL

Generic Medicines

₹10 avg. patient cost
  • Active Ingredients: 100% Identical formula & strength
  • Bioequivalence: Identical therapeutic effect & absorption
  • Manufacturing: WHO-GMP / FDA Certified Plants
  • Government Endorsed: PMBJP / Jan Aushadhi Approved
  • Supply-Chain Savings: 80% to 90% Direct Sourced Discount
VS
RETAIL STANDARD

Branded Medicines

₹100 avg. patient cost
  • Active Ingredients: 100% Identical formula & strength
  • Bioequivalence: Identical therapeutic effect & absorption
  • Manufacturing: WHO-GMP / FDA Certified Plants
  • Commercial Markup: Up to 800% marketing & ad inflation
  • Patient Burden: Full brand premium pricing

Recently viewed products